Wednesday, June 12 2024
8:55–9:40am
Industry Theater
XHANCE: The First and Only FDA-approved Treatment for Chronic Rhinosinusitis Without Nasal Polyps in Adults
Description
XHANCE (fluticasone propionate): New Data Leads to FIRST and ONLY FDA Approved Treatment for this Indication